These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9847978)

  • 1. Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease.
    Lamarche B
    Coron Artery Dis; 1998; 9(8):473-81. PubMed ID: 9847978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health consequences of visceral obesity.
    Després JP
    Ann Med; 2001 Nov; 33(8):534-41. PubMed ID: 11730160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
    Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
    Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidaemia and obesity.
    Després JP
    Baillieres Clin Endocrinol Metab; 1994 Jul; 8(3):629-60. PubMed ID: 7980350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
    Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP
    Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
    Després JP
    Obes Res; 1998 Apr; 6 Suppl 1():8S-17S. PubMed ID: 9569171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease under the influence of excess visceral fat.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative effects of obesity and insulin resistance on cardiovascular risk factors in nondiabetic and normotensive men.
    Park SH; Lee WY; Lee YS; Rhee EJ; Kim SW
    Korean J Intern Med; 2004 Jun; 19(2):75-80. PubMed ID: 15366636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinaemia, obesity, and syndrome X.
    Zavaroni I; Bonini L; Fantuzzi M; Dall'Aglio E; Passeri M; Reaven GM
    J Intern Med; 1994 Jan; 235(1):51-6. PubMed ID: 8283160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
    Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fibric acid derivatives in the management of risk factors for coronary heart disease.
    Després JP; Lemieux I; Robins SJ
    Drugs; 2004; 64(19):2177-98. PubMed ID: 15456334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
    Quispe R; Martin SS; Jones SR
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Body fat distribution: its characteristics and relationship to cardiovascular risk factors in obese Chinese].
    Ran XW; Li XS; Tong NW; Li QF; Tang BD; Li XJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):699-703. PubMed ID: 15460424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary risk profiles in men with coronary artery disease: effects of body composition, fat distribution, age and fitness.
    Brochu M; Poehlman ET; Savage P; Ross S; Ades PA
    Coron Artery Dis; 2000 Mar; 11(2):137-44. PubMed ID: 10758815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy?
    Imbeault P; Lemieux S; Prud'homme D; Tremblay A; Nadeau A; Després JP; Mauriège P
    Metabolism; 1999 Mar; 48(3):355-62. PubMed ID: 10094113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL particle size, fat distribution and insulin resistance in obese children.
    Miyashita M; Okada T; Kuromori Y; Harada K
    Eur J Clin Nutr; 2006 Mar; 60(3):416-20. PubMed ID: 16278685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic heart disease as an effect of obesity-related metabolic disturbances.
    Indulski JA; Lutz W
    Cent Eur J Public Health; 1999 Aug; 7(3):122-9. PubMed ID: 10499142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.